Sharmila Anandasabapathy

Dr. Sharmila Anandasabapathy


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2015 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
MPMarion-Anna Protano
Marion-Anna Protano
HXHong Xu
Hong Xu
GWGuiqi Wang
Guiqi Wang
APAlexandros D. Polydorides
Alexandros D. Polydorides
SDSanford M. Dawsey
Sanford M. Dawsey
SASharmila Anandasabapathy
Sharmila Anandasabapathy

1 April 2010 in Technology in Cancer Research & Treatment
Verified
Journal Article
Open access
PDF file
NBNoah Bedard
Noah Bedard
MPMark Pierce
Mark Pierce
AEAdel K. El-Naggar
Adel K. El-Naggar
SASharmila Anandasabapathy
Sharmila Anandasabapathy
AGAnn Gillenwater
Ann Gillenwater
RRRebecca Richards-Kortum
Rebecca Richards-Kortum
Medical imaging technologies have become increasingly important in the clinical management of cancer, and now play key roles in cancer screening, diagnosis, staging, and monitoring response to treatment. Standard imaging modalities such as MRI, PET, and CT require significant financial resources and infrastructure, which limits access to these modalities to those patients in high-resource settings. In contrast, optical imaging strategies, with the potential for reduced cost and enhanced portability, are emerging as additional tools to facilitate the early detection and diagnosis of cancer. This article presents a vision for an expanding role for optical imaging in global cancer management, including screening, early detection at the point-of-care, biopsy guidance, and real-time histology. Multi-modal optical imaging - the combination of widefield and high resolution imaging - has the potential to aid in the detection and management of precancer and early cancer for traditionally underserved populations. Several recent widefield and high-resolution optical imaging technologies are described, along with requirements for implementing such devices into lower-resource settings.

1 November 2014 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Closed access
JLJustin S. Louie
Justin S. Louie
RRRebecca Richards-Kortum
Rebecca Richards-Kortum
SASharmila Anandasabapathy
Sharmila Anandasabapathy

1 April 2007 in Seminars in Oncology
Verified
Journal Article
Closed access
JIJulie G. Izzo
Julie G. Izzo
RLRajyalakshmi Luthra
Rajyalakshmi Luthra
TWTseung-Teh Wu
Tseung-Teh Wu
ACArlene M. Correa
Arlene M. Correa
MLMadan Luthra
Madan Luthra
Jaffer AjaniJaffer Ajani
Jaffer Ajani

3 June 2024 in Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences
Verified
Journal Article
Open access
JKJoe Knapper
Joe Knapper
FWFreya Whiteford
Freya Whiteford
DRDaniel Rosen
Daniel Rosen
WWWilliam Wadsworth
William Wadsworth
JSJulian Stirling
Julian Stirling
RBRichard Bowman
Richard Bowman
The OpenFlexure Microscope is an accessible, three-dimensional-printed robotic microscope, with sufficient image quality to resolve diagnostic features including parasites and cancerous cells. As access to lab-grade microscopes is a major challenge in global healthcare, the OpenFlexure Microscope has been developed to be manufactured, maintained and used in remote environments, supporting point-of-care diagnosis. The steps taken in transforming the hardware and software from an academic prototype towards an accepted medical device include addressing technical and social challenges, and are key for any innovation targeting improved effectiveness in low-resource healthcare. This article is part of the Theo Murphy meeting issue 'Open, reproducible hardware for microscopy'.

19 November 2021 in Vaccines
Verified
Journal Article
Open access
PDF file
EPElena V. Petrova
Elena V. Petrova
TFTimothy Farinholt
Timothy Farinholt
TJTejas Joshi
Tejas Joshi
HMHannah Moreno
Hannah Moreno
MMMayar Al Mohajer
Mayar Al Mohajer
SASharmila Anandasabapathy
Sharmila Anandasabapathy
Vaccine uptake is a multifactor measure of successful immunization outcomes that includes access to healthcare and vaccine hesitancy for both healthcare workers and communities. The present coronavirus disease (COVID-19) pandemic has highlighted the need for novel strategies to expand vaccine coverage in underserved regions. Mobile clinics hold the promise of ameliorating such inequities, although there is a paucity of studies that validate environmental infection in such facilities. Here, we describe community-based management of COVID-19 through a Smart Pod mobile clinic deployed in an underserved community area in the United States (Aldine, Harris County, TX, USA). In particular, we validate infection control and biological decontamination of the Smart Pod by testing surfaces and the air-filtration system for the COVID-19 virus and bacterial pathogens. We show the Smart Pod to be efficacious in providing a safe clinical environment for vaccine delivery. Moreover, in the Smart Pod, up-to-date education of community healthcare workers was provided to reduce vaccine hesitancy and improve COVID-19 vaccine uptake. The proposed solution has the potential to augment existing hospital capacity and combat the COVID-19 pandemic locally and globally.